Skip to Content
Merck
  • Critical role for the protons in FRTL-5 thyroid cells: nuclear sphingomyelinase induced-damage.

Critical role for the protons in FRTL-5 thyroid cells: nuclear sphingomyelinase induced-damage.

International journal of molecular sciences (2014-07-01)
Elisabetta Albi, Giuseppina Perrella, Andrea Lazzarini, Samuela Cataldi, Remo Lazzarini, Alessandro Floridi, Francesco Saverio Ambesi-Impiombato, Francesco Curcio
ABSTRACT

Proliferating thyroid cells are more sensitive to UV-C radiations than quiescent cells. The effect is mediated by nuclear phosphatidylcholine and sphingomyelin metabolism. It was demonstrated that proton beams arrest cell growth and stimulate apoptosis but until now there have been no indications in the literature about their possible mechanism of action. Here we studied the effect of protons on FRTL-5 cells in culture. We showed that proton beams stimulate slightly nuclear neutral sphingomyelinase activity and inhibit nuclear sphingomyelin-synthase activity in quiescent cells whereas stimulate strongly nuclear neutral sphingomyelinase activity and do not change nuclear sphingomyelin-synthase activity in proliferating cells. The study of neutral sphingomyelinase/sphingomyelin-synthase ratio, a marker of functional state of the cells, indicated that proton beams induce FRTL-5 cells in a proapoptotic state if the cells are quiescent and in an initial apoptotic state if the cells are proliferating. The changes of cell life are accompanied by a decrease of nuclear sphingomyelin and increase of bax protein.

MATERIALS
Product Number
Brand
Product Description

Avanti
16:0 SM (d18:1/16:0), Avanti Polar Lipids, powder
Avanti
12:0 SM (d18:1/12:0), Avanti Polar Lipids 860583P, powder
Avanti
24:0 SM, Avanti Polar Lipids 860592P, powder
Avanti
C20 Ceramide (d18:1/20:0), Avanti Polar Lipids 860520P, powder
Avanti
C16 Ceramide (d18:1/16:0), Avanti Polar Lipids
Avanti
C18 Ceramide (d18:1/18:0), Avanti Polar Lipids
Avanti
C24 Ceramide (d18:1/24:0), Avanti Polar Lipids
Avanti
18:1 SM (d18:1/18:1(9Z)), Avanti Polar Lipids 860587C
Avanti
18:1 SM (d18:1/18:1(9Z)), Avanti Polar Lipids 860587P, powder